Franklin Resources Inc Syndax Pharmaceuticals Inc Put Options Transaction History
Franklin Resources Inc
- $378 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SNDX
# of Institutions
261Shares Held
101MCall Options Held
1.3MPut Options Held
1.24M-
Kynam Capital Management, LP Princeton, NJ8.52MShares$142 Million11.08% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$132 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.8MShares$96.6 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.14MShares$85.6 Million0.0% of portfolio
-
State Street Corp Boston, MA3.85MShares$64.2 Million0.0% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $942M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...